Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same

   
   

A non-polydispersed mixture of conjugates in which each conjugate in the mixture comprises a drug coupled to an oligomer that includes a polyalkylene glycol moiety is disclosed. The mixture may exhibit higher in vivo activity than a polydispersed mixture of similar conjugates. The mixture may be more effective at surviving an in vitro model of intestinal digestion than polydispersed mixtures of similar conjugates. The mixture may result in less inter-subject variability than polydispersed mixtures of similar conjugates.

A non-polydispersed la miscela dei coniugati in cui ogni coniugato nella miscela contiene una droga accoppiata ad un oligomero che include una parte del glicol del polyalkylene è rilevato. La miscela può esibire l'più alta attività in vivo che la a polydispersed la miscela dei coniugati simili. La miscela può essere più efficace alla sopravvivenza un modello in vitro di digestione intestinale delle miscele dei coniugati simili. La miscela può provocare meno variabilità dell'inter-oggetto delle miscele dei coniugati simili.

 
Web www.patentalert.com

< Process for making antifusogenic fusion peptides that form inclusion bodies

< .alpha.-hydroxyarylbutanamine inhibitors of aspartyl protease

> Composition containing porous microparticle impregnated with biologically-active compound for treatment of infection

> Pituitary tumor transforming gene (PTTG) carboxy-terminal peptides and methods of use thereof to inhibit neoplastic cellular proliferation and/or transformation

~ 00163